Pubmed ID |
Author |
Year |
Title |
19563188
|
Xu J
|
2009
|
[Effect of electroacupuncture combined with auricular point tapping and pressing on serum insulin and testosterone in the patients of obese women with polycystic ovary syndrome].
|
19567450
|
Yildiz BO
|
2010
|
Visually scoring hirsutism.
|
19567514
|
Victor VM
|
2009
|
Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance.
|
19567518
|
Vassiliadi DA
|
2009
|
Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.
|
19567524
|
Hickey M
|
2009
|
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.
|
19567527
|
Maliqueo M
|
2009
|
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.
|
19567528
|
Ropelato MG
|
2009
|
Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents.
|
19570211
|
Salvetti NR
|
2009
|
An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats.
|
19570444
|
Li L
|
2009
|
[Effect of anti-M?llerian hormone on P450 aromatase mRNA expression in cultured human luteinized granulose cells].
|
19571257
|
Rzepczynska IJ
|
2009
|
Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.
|
19572227
|
Vrbikova J
|
2009
|
Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus.
|
19573285
|
Delvigne A
|
2009
|
Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS.
|
19573754
|
Schuster DP
|
2009
|
Changes in physiology with increasing fat mass.
|
19573758
|
Hassink SG
|
2009
|
Weighing risk: the expert committee's recommendations in practice.
|
19574176
|
Rashidi B
|
2009
|
The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.
|
19574280
|
Sproul K
|
2009
|
Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.
|
19574398
|
Rice S
|
2009
|
Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway.
|
19576817
|
Barfield E
|
2009
|
The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
|
19577236
|
Tamimi W
|
2009
|
Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome.
|
19580099
|
Heng BC
|
2009
|
Should patients diagnosed with polycystic ovary syndrome (PCOS) participate in compensated egg sharing in return for subsidized fertility treatment?
|
19580964
|
Svendsen PF
|
2010
|
The insulin-resistant phenotype of polycystic ovary syndrome.
|
19583806
|
Papachroni KK
|
2010
|
Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue.
|
19584198
|
Berga SL
|
2009
|
Polycystic ovary syndrome: a model of combinatorial endocrinology?
|
19584394
|
Eckmann KR
|
2009
|
Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
|
19585163
|
de Sousa G
|
2010
|
A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents.
|
19585444
|
Kunz J
|
2009
|
[18-year-old woman with an ovarian tumour detected by coincidence].
|
19585478
|
Grant P
|
2010
|
Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial.
|
19588338
|
Tang T
|
2009
|
WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
|
19589515
|
Sum M
|
2009
|
Hypothalamic amenorrhea in young women with underlying polycystic ovary syndrome.
|
19589517
|
Hourvitz A
|
2010
|
In vitro maturation for patients with repeated in vitro fertilization failure due to oocyte maturation abnormalities.
|
19589523
|
Bohler H Jr
|
2010
|
Adipose tissue and reproduction in women.
|
19590426
|
Yavasoglu I
|
2009
|
A novel association between polycystic ovary syndrome and Helicobacter pylori.
|
19590590
|
Ciccone MM
|
2009
|
Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
|
19591017
|
Deligeoroglou E
|
2009
|
The role of genes in the polycystic ovary syndrome: predisposition and mechanisms.
|
19591981
|
Battaglia C
|
2010
|
Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study.
|
19591997
|
Chen MJ
|
2009
|
The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.
|
19593320
|
Alexander CJ
|
2009
|
Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
|
19595057
|
Tao MF
|
2009
|
[Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
|
19596311
|
Fan P
|
2009
|
Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome.
|
19602270
|
Sun J
|
2009
|
Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.
|
19602786
|
Bilgir O
|
2009
|
The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).
|
19605540
|
Carmina E
|
2009
|
Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
|
19608164
|
Api M
|
2009
|
Could transvaginal, ultrasound-guided ovarian interstitial laser treatment replace laparoscopic ovarian drilling in women with polycystic ovary syndrome resistant to clomiphene citrate?
|
19609045
|
Tsutsumi R
|
2009
|
GnRH pulsatility, the pituitary response and reproductive dysfunction.
|
19609106
|
Priyadarshani A
|
2009
|
Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
|
19610519
|
Sultana A
|
2008
|
Pituitary gonadotropic hormones in women with oligo/amenorrhoea.
|
19615041
|
Li Y
|
2009
|
Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo.
|
19617605
|
Nardo LG
|
2009
|
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
|
19621836
|
Millea PJ
|
2009
|
N-acetylcysteine: multiple clinical applications.
|
19622037
|
Herken H
|
2009
|
The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.
|
19622210
|
Wilkes S
|
2009
|
Obesity and female fertility: a primary care perspective.
|
19622617
|
Cussons AJ
|
2009
|
Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.
|
19622949
|
Keller J
|
2009
|
Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.
|
19625203
|
Kowalska I
|
2009
|
The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes.
|
19627713
|
Roa Barrios M
|
2009
|
[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
|
19628650
|
Wehr E
|
2009
|
Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
|
19629068
|
Tang T
|
2009
|
A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization.
|
19631369
|
Villavicencio A
|
2009
|
Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.
|
19631445
|
Vural P
|
2009
|
Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
|
19632551
|
Pastore LM
|
2009
|
Recruitment strategies for an acupuncture randomized clinical trial of reproductive age women.
|
19634921
|
Katsiki N
|
2009
|
The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
|
19635611
|
Molinaro TA
|
2009
|
A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry.
|
19636212
|
Sun L
|
2010
|
Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
|
19639497
|
G?ven A
|
2010
|
Adiponectin and resistin concentrations after glucose load in adolescents with polycystic ovary syndrome.
|
19639500
|
Akram T
|
2010
|
Association of polycystic ovary syndrome with cardiovascular risk factors.
|
19639923
|
Abdel-Gadir A
|
2009
|
Coexistence of polycystic ovaries and uterine fibroids and their combined effect on the uterine artery blood flow in relation to age and parity.
|
19640893
|
Amer SA
|
2009
|
The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy.
|
19641007
|
Ryan J
|
2009
|
An audit of oral glucose tolerance tests at a large teaching hospital: indications, outcomes and confounding factors.
|
19642982
|
Dadgostar H
|
2009
|
The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes.
|
19644950
|
Lam P
|
2009
|
Three-dimensional ultrasound features of the polycystic ovary in Chinese women.
|
19646674
|
Shah AA
|
2009
|
Early polycystic ovary syndrome as a possible etiology of unexplained premenarcheal ovarian torsion.
|
19648034
|
Bekx MT
|
2010
|
Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.
|
19648752
|
Zheng Q
|
2009
|
Family-based association study of the MCF2L2 gene and polycystic ovary syndrome.
|
19648857
|
Dara? E
|
2009
|
Transvaginal hydrolaparoscopy.
|
19650762
|
Pasquali R
|
2009
|
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
|
19654109
|
Mueller A
|
2009
|
Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.
|
19655157
|
Kebapcilar L
|
2010
|
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
|
19668673
|
Orsino A
|
2005
|
Clinical features, investigations and management of adolescents with polycystic ovary syndrome.
|
19671519
|
Economou F
|
2009
|
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.
|
19672087
|
Vrbikova J
|
2009
|
Impaired glucose metabolism in women with polycystic ovary syndrome.
|
19676066
|
Lam P
|
2009
|
Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic.
|
19680559
|
Feng Y
|
2009
|
Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
|
19681917
|
San-Mill?n JL
|
2010
|
The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence.
|
19681918
|
Sathyapalan T
|
2010
|
Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS).
|
19686401
|
Percy CA
|
2009
|
Nurse-led peer support group: experiences of women with polycystic ovary syndrome.
|
19686552
|
DuRant EM
|
2009
|
Managing polycystic ovary syndrome: a cognitive behavioral strategy.
|
19688205
|
Drohobyczer D
|
2010
|
Polycystic ovaries in leprechaunism.
|
19688613
|
Lee H
|
2009
|
The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
|
19689407
|
Reismann P
|
2009
|
Pharmacological options for treatment of hyperandrogenic disorders.
|
19692420
|
Prodoehl MJ
|
2009
|
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.
|
19692630
|
Aubuchon M
|
2009
|
Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS).
|
19693712
|
Petrik JJ
|
2009
|
Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.
|
19693748
|
Qiu S
|
2009
|
Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome.
|
19697132
|
Mathur R
|
2010
|
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.
|
19697191
|
Leeman L
|
2009
|
The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
|
19698287
|
Zurvarra FM
|
2009
|
Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
|
19700147
|
Gada D
|
2009
|
Luteal-phase clomiphene citrate in PCOS.
|
19700156
|
Karkanaki A
|
2009
|
Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.
|
19700609
|
Franks S
|
2009
|
Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized.
|
19702452
|
Hirschberg AL
|
2009
|
Polycystic ovary syndrome, obesity and reproductive implications.
|